STT
48
4
HSIC
42
2
KO
44
2
OMC
37
2
KLAC
45
3
RRC
52
2
PEP
33
4
HPQ
55
3
AN
49
2
FSLR
50
6
EXPD
29
2
ABBV
40
5
IVZ
42
13
GOOGL
62
6
CHD
34
7
PSA
43
6
GE
60
5
PNC
48
6
AIG
38
5
ES
12
3
STT
48
4
HSIC
42
2
KO
44
2
OMC
37
2
KLAC
45
3
RRC
52
2
PEP
33
4
HPQ
55
3
AN
49
2
FSLR
50
6
EXPD
29
2
ABBV
40
5
IVZ
42
13
GOOGL
62
6
CHD
34
7
PSA
43
6
GE
60
5
PNC
48
6
AIG
38
5
ES
12
3
Financhill
Back

Sarepta Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
36

SRPT
Sarepta Therapeutics

Last Price:
$118.99
Seasonality Move:
12.18%
Buy
55

CPRX
Catalyst Pharmaceuticals

Last Price:
$21.26
Seasonality Move:
6.88%
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.27. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $118.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.28 Sell
Chaikin Money Flow: -1117882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.92 - 130.54) Sell
Bollinger Bands (100): (118.37 - 135.77) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 45.6 Sell
Chaikin Money Flow: 513844 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.15 - 22.07) Sell
Bollinger Bands (100): (19.14 - 22.14) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.1 Sell
20-day SMA: 125.31 Sell
50-day SMA: 122.99 Sell
200-day SMA: 129.64 Sell
8-day EMA: 122.43 Sell
20-day EMA: 123.17 Sell
50-day EMA: 123.7 Sell
200-day EMA: 126 Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.56 Sell
20-day SMA: 21.76 Sell
50-day SMA: 21.71 Sell
200-day SMA: 18.26 Buy
8-day EMA: 21.55 Sell
20-day EMA: 21.68 Sell
50-day EMA: 21.43 Sell
200-day EMA: 18.86 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):